Literature DB >> 22075410

Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents.

Masamichi Takano1, Daisuke Murakami, Masanori Yamamoto, Osamu Kurihara, Koji Murai, Toru Inami, Nakahisa Kimata, Takayoshi Ohba, Yoshihiko Seino, Kyoichi Mizuno.   

Abstract

BACKGROUND: Although several clinical trials have shown the superior efficacy and safety of second-generation everolimus-eluting stents (EES) in comparison with first-generation paclitaxel-eluting stents (PES), the differences in the vascular healing process between EES and PES in a human coronary artery during an early stage are unknown.
METHODS: A prospective optical coherence tomography (OCT) observation was performed for 25 EES in 21 patients and 27 PES in 21 patients at 6 months after implantation. Cross-sections within single-stent segments were analyzed at intervals of 1mm. The neointimal (NI) thickness on each strut was measured. Uncovered struts (NI thickness=0 μm), malapposed struts, NI area (%), uncovered strut ratio >0.3 (UCSR; number of uncovered struts/number of total struts) per cross-section, and in-stent thrombus were evaluated.
RESULTS: A total of 5198 EES struts in 514 cross-sections and 4243 PES struts in 469 cross-sections were identified. NI thickness and its area were smaller for EES than PES (80.0 ± 84.8 μm vs. 117.9 ± 140.0 μm and 19.1 ± 8.9% vs. 23.7 ± 11.5%, respectively; P<0.001). The frequencies of uncovered struts and malapposed struts were lower in EES compared to PES (2.3% vs. 5.2% and 2.1% vs. 5.7%, respectively; P<0.001). Patients who had cross-sections of UCSR >0.3 and thrombi were identified less frequently in EES than in PES group (5% vs. 57%; P<0.001, and 19% vs. 48%; P=0.05, respectively).
CONCLUSIONS: Six-month OCT examination showed a favorable vessel healing response after the implantation of EES, demonstrating less in-stent late loss as well as fewer uncovered struts and better stent apposition to the vessel wall in comparison with PES.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075410     DOI: 10.1016/j.ijcard.2011.10.102

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  A review in enormity of OCT and its enduring understanding of vulnerable plaque in coronary bifurcation lesion.

Authors:  Rajiv Shrestha; Aanchal Shrestha; Jing Kan; Shaoliang Chen
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-01       Impact factor: 2.357

2.  Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.

Authors:  Norihiro Kobayashi; Yoshiaki Ito; Masahiro Yamawaki; Motoharu Araki; Tsuyoshi Sakai; Yasunari Sakamoto; Shinsuke Mori; Masakazu Tsutsumi; Masahiro Nauchi; Yohsuke Honda; Takahiro Tokuda; Kenji Makino; Shigemitsu Shirai; Keisuke Hirano
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-20       Impact factor: 2.357

3.  Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.

Authors:  Manel Sabaté; Stephan Windecker; Andres Iñiguez; Lisette Okkels-Jensen; Angel Cequier; Salvatore Brugaletta; Sjoerd H Hofma; Lorenz Räber; Evald Høi Christiansen; Maarten Suttorp; Thomas Pilgrim; Gerrit Anne van Es; Yohei Sotomi; Hector M García-García; Yoshinobu Onuma; Patrick W Serruys
Journal:  Eur Heart J       Date:  2015-09-23       Impact factor: 29.983

4.  Optical Coherence Tomography Imaging: Novel Insights into the Vascular Response After Coronary Stent Implantation.

Authors:  Milosz Jaguszewski; Ulf Landmesser
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-05-05

Review 5.  Stent evaluation with optical coherence tomography.

Authors:  Seung-Yul Lee; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

6.  Difference of vascular response between everolimus- and paclitaxel-eluting stents for small coronary artery disease: Optical coherence tomography analysis.

Authors:  Kenya Nasu; Yuji Oikawa; Tadanori Aizawa; Takahiko Suzuki
Journal:  Int J Cardiol Heart Vessel       Date:  2014-02-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.